Ready to play
Ready to play
A new drug for lung cancer treatment has received rapid approval in the United States, primarily used for patients who are ineligible for surgery. The medication aims to improve survival rates and reduce symptoms for those affected by this type of cancer.
Notice: This Is an AI-Generated Summary
Comments (0)